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Carbapenem-resistant Enterobacteriaceae (CRE) is spreading in 
worldwide and has become endemic in several countries, including 
Italy [1,2]. The global dissemination of carbapenem-resistant 
Enterobacteriaceae is mostly due to strains of Klebsiella pneumoniae 
and less frequently of other species producing various types of 
acquired carbapenemases [3]. However, antimicrobials (such as 
carbapenems, cephalosporin) which are widely used in the treatment 
of K. pneumoniae infection have been proven to be a major factor 
to mortality and morbidity in settings with limited diagnostic 
facilities and treatment options [4], especially in increasing emergent 
multidrug resistant (MDR) K. pneumoniae. MDR K. pneumoniae, 
internationally defined as having non-susceptibility to at least three 
classes of antibiotics or more [5], poses tremendous threat to clinical 
setups in hospitals. Resistance to carbapenem by such enzyme 
is a global concern due to limited therapeutic options and their 
association with life-threatening infections. Large referral hospitals 
and teaching institutions are at great risk for a widespread outbreak 
of infections and responsible for the spread of such strains from one 
location to another and to other hospitals. Experiences in individual 
hospitals or in whole countries they have shown how it is possible 
to eradicate or contain strongly the spread of Enterobacteria strains 
producing carbapenemases through aggressive infection control 
interventions in the health sector, aimed at promptly identifying cases 
of clinically evident infections and colonized patients and promptly 
adopting stringent measures of containment of dissemination 
(isolation of colonized or infected patients, hand hygiene, cleaning 
and environmental contamination, etc.) [6].
In this report we present the phenotypic and molecular 
characterizations of KPC-producing carbapenem-resistant K. 
pneumonia clinical isolates in an Italian hospital.
The study included thirty-eight isolates obtained from the following 
samples: rectal swab (n=14), urine (n=10), bronchoalveolar lavage 
(BAL; n=8) and wound swab (n=6).
Species identification and antimicrobial susceptibility testing were 
carried out using the Vitek 2 system and the ASTGN201 cards (bio 
Merieux, Florence, Italy).
Carbapenemase production was confirmed by a disc diffusion 
synergy test including meropenem and two carbapenemase-
inhibiting compounds (ethylenediaminetetraacetic acid EDTA, and 
boronic acid) [7].
PCR screening was performed with cell lysates for identification 
of the carbapenemase genes using specific bla primers designed 
for identifying known β-lactamase genes including, blaKPC; blaIMP, 
blaVIM, blaOXA48, blaNDM [8,9] cellular debris were removed by 
centrifugation at 17,310 g for 5 min. aliquot of 2 µl of the supernatant 
used as DNA template for PCR [10]. PCR-positive amplicons were 
purified by the QIA quick PCR Purification Kit according to the 
manufacturer’s instructions (Qiagen, Milan, Italy) and directly 
sequenced using amplification primers on the 3130 Genetic Analyzer 
(Applied Biosystem, Milan, Italy). Purification and sequencing were 
carried out by Genexs.r.o. (CZ, Czech Republic). Sequence alignment 
and analysis were performed online using the BLAST program of the 
National Center for Biotechnology Information (www.ncbi.nlm.nih.
gov).
The K. pneumonia isolates underwent molecular typing by means 
of the MLST technique were performed using seven conserved 
housekeeping genes (gapA, infB, mdh, pgi, phoE, rpoB, tonB) [11]. 
A detailed protocol of the MLST procedure, including allelic type and 
sequence type (ST) assignment methods, is available in MLST databases 
from Pasteur Institute, Paris, France at the following website (http://
www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.html).
MICs of imipenem and meropenem in the range of 4 mg/L to ≥16 
mg/L and 1 mg/L to ≥16 mg/L, respectively, were observed. The tested 
strains were analyzed for the presence of resistance mechanisms 
against β-lactam antibiotics using PCR amplifications for bla genes 
responsible for carbapenemases production (blaKPC, blaVIM, blaIMP, 
blaNDM and blaOXA-48).
Overall, 38 out of the 34 isolates were positive for the blaKPC gene, 2 
for the blaVIM metallo-b-lactamase and 2 for the blaOXA-48 gene; while 
all were negative for NDM gene. Sequence analysis of the entire genes 
revealed perfect identity with the blaKPC-2(20/38), blaKPC-3 (18/38), 
blaVIM-1 (2/18) and blaOXA-48 (2/38) genes.
Multi Locus Sequence Typing showed that the ST258 clone was 
typical of the KPC-2 producing strains, while the ST512 clone was 
characteristic of the 5 blaKPC-3 producing strains, were previously 
reported in Italy [12,13].
Recognition of different carbapenem-non-susceptible clones by 
molecular epidemiological tools is an important step towards tracing 
transmission routes, developing targeted control and prevention 
strategies, and monitoring their effectiveness.
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In addition, the KPC and IMP genes are usually associated with 
mobile genetic elements that can efficiently disseminate to other 
bacteria in the hospital environment [14,15]. It is therefore important 
to emphasize the prompt recognition and establishment of proper 
therapeutic and infection control measures in order to reduce the 
spread of infections caused by these highly resistant organism.
The accurate detection of this emerging public health threat clone is 
crucial both for the selection of appropriate therapeutic regimens and 
for controlling the spread of KPC-type enzymes.
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